Scope Fluidics S.A. of Warsaw at MEDICA 2021 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option

Scope Fluidics S.A.

Duchnicka 3 Bldg.16, 01-796 Warsaw
Poland

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
Poland Pavilion

Hall map

MEDICA 2021 hall map (Hall 16): stand D42

Fairground map

MEDICA 2021 fairground map: Hall 16

Contact

Gajane Zurawska

Phone
+48601997720

Email
gajane.zurawska@scopefluidics.com

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.03  Polymerase chain reaction (PCR)

Our products

Product category: Polymerase chain reaction (PCR)

PCR|ONE The fastest point-of-care PCR

Scope Fluidics founded Curiosity Diagnostics to create the PCR|ONE system that delivers the fastest bacterial and viral pathogen detection in the world.
This fully automated procedure identifies up to 20 distinct pathogens and drug-resistant genes.

More Less

Product category: Polymerase chain reaction (PCR)

BacterOMIC Most comprehensive AST

The emergence and rapid spread of drug resistance among bacteria constitutes a major threat to public health worldwide. In the absence of new antibiotics, better diagnostics is the only solution. We are now developing an automated culturing system delivering the most comprehensive information on bacterial susceptibility to all known antibiotics and on the resistance mechanisms.

More Less

About us

Company portrait

Scope Fluidics develops innovative projects in the field of diagnostics and health care.

The company was established in 2010 in the Institute of Physical Chemistry of the Polish Academy of Sciences with the aim of creating solutions for medicine based on microfluidic technologies. The company cooperates with the academia, and integrates the points of view of medicine and business to develop innovative solutions with a high market potential.

Within the Capital Group, Scope Fluidics has its own experts in finance, administration and legal issues that are used by the companies which belong to the Group. Scope Fluidics provides the source of funding, as it transfers to special purpose entities the money needed to cover the cost of R&D works and provides the so-called own resources for EU funding. Company’s business model provides for the development and business verification of a project, followed by the establishment of a special purpose entity within which the whole project is developed.

Scope Fluidics includes two special purpose entities: Curiosity Diagnostics Sp. z o.o. and Bacteromic Sp. z o.o.

During the years 2012-2015, Curiosity Diagnostics worked on the technology of rapid analysis of the genetic material of bacterial and viral pathogens. The outcome of these works is currently used in the delivery of the PCR|ONE project. On the other hand, Bacteromic developed its own system, named after the company. This project will combine innovative microfluidic technology with traditional microbiological methods of drug resistance testing in order to obtain information on pathogen’s drug resistance and select the best treatment that is tailored to patient’s individual needs.

Since 2017, Scope Fluidics S.A. has been listed on the NewConnect stock exchange.

Read more: www.scopefluidics.com